Impact of self-measurement of blood pressure and self-adjustment of antihypertensive medication in the control of hypertension and adherence to treatment. A pragmatic, randomized, controlled clinical trial (ADAMPA Study)

Instituto de Investigación Sanitaria INCLIVA0 个研究点目标入组 458 人开始时间: 2017年3月17日最近更新: 2021年1月5日

适应症

试验速览

暂无简介。

•- 40 years or older
•- have a diagnosis of hypertension of any origin
•- have a TAS> 145 or TAD> 90 mm Hg on the baseline examination
•- voluntarily agree to participate in the study and sign the corresponding informed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 158
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 300

•- inability to self-care of their blood pressure, understanding, performing and / or self-adjusting of medication by the patient, including dementia or significant cognitive impairment at the discretion of the investigator performing the recruitment
•- history of orthostatic hypotension (fall> 20 mm Hg in systolic arterial tension after the orthostatic position)
•- have a blood pressure> 200 or diastolic blood pressure> 100 mm Hg at baseline
•- being on treatment with more than 4 antihypertensive drugs
•- be included in another high blood pressure study or in a clinical trial
•- presence of tremor or neurological disease that makes it difficult to perform AMPA
•- presence of arrhythmia
•- presence of terminal illness
•- chronic incapacitation to leave your home
•- have had an acute cardiovascular event in the last 3 months
•- arterial hypertension managed directly by specialist physicians outside the Primary Care setting
•- spouse selected for the study
•- non-resident or transient patients

发起方

Instituto de Investigación Sanitaria INCLIVA